TickerFactsScreenerDevelopers

Vivos Therapeutics, Inc. (VVOS) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2019: $175.6K2020: $120.0K2021: $2.40M2022: $924.0K2023: $803.0K2024: $568.0K2025: $2.34M$2.34M
2019Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$2.34M+312.1%
2024$568.0K-29.3%
2023$803.0K-13.1%
2022$924.0K-61.4%
2021$2.40M+1896.7%
2020$120.0K-31.7%
2019$175.6K—